Resultados de la búsqueda 691-700 of 4457 for treatment resistant depression
E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS). Rochester, Minn., Jacksonville, Fla., Scottsdale ...
Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester, Minn., Mankato, Minn., La Crosse, Wis ...
... treatment, while rates of disease control during ... resistance to 131I-MIBG and crizotinib. A Study ... This is a phase 1b/2 study of the safety and efficacy of ...
The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...
The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.
The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...
... treatment, while rates of disease control during ... resistance to 131I-MIBG and crizotinib. ... A Study to Evaluate the Effectiveness and Safety of Remdesivir to ...
Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
... treatment, while rates of disease control during ... resistance to 131I-MIBG and crizotinib. Safety ... This is a phase 1b/2 study of the safety and efficacy of ...
This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.